Cafepharma Today

May 19 2025 - Regeneron wins bid to buy 23andMe out of bankruptcy
Regeneron wins bid to buy 23andMe out of bankruptcy
Amid US investment push, Lilly eyes Houston as potential home for $5.9B API plant
Japan follows UK in GSK's comeback tour for Blenrep
FDA clears Novavax’s COVID-19 vaccine with usage restrictions
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Forbes Earnings Preview: Abbott Laboratories
Forbes
Monday, October 15, 2012 - 10:43am
tags:
earnings, Abbott Labs
Biotech Investors: Are We Blinded By Clinical Trials?
Seeking Alpha
Monday, October 15, 2012 - 10:42am
tags:
clinical trials, Abbott Labs, Aeterna Zentaris, Dendreon, Keryx
Lilly's gastric cancer drug meets late-stage goal
Reuters
Monday, October 15, 2012 - 10:41am
tags:
gastric cancer, Eli Lilly, ramucirumab
Kythera Biopharmaceuticals: Successful Offering Of This One-Drug Company Backed By Bayer
Seeking Alpha
Monday, October 15, 2012 - 10:37am
tags:
Kythera, IPOs, facial aesthetics
Is Wall Street Too Eager To Get Excited About Eli Lilly's Alzheimer's Drug?
Forbes
Monday, October 15, 2012 - 10:36am
tags:
Eli Lilly, Alzheimer's disease, solanezumab
Aegerion Vs. Isis: Which One Is The Buy?
Seeking Alpha
Monday, October 15, 2012 - 10:35am
tags:
Isis Pharmaceuticals, Aegerion, FDA, advisory panels, mipomersen, lomitapide
Will Expedited Approval Spell Fat Profits for Drug Makers?
Motley Fool
Sunday, October 14, 2012 - 11:22am
tags:
Is This Giant Drug Stock a Buy, Hold or Sell Today?
Wall St Cheat Street
Sunday, October 14, 2012 - 11:21am
tags:
Merck
Breckenridge announces agreement with Marksans Pharma, Ltd. to market Gabapentin Capsules By Breckenridge Pharmaceutical, Inc.
Sacramento Bee, CA
Sunday, October 14, 2012 - 11:20am
tags:
gabapentin, Breckenridge, Marksans Pharma
5 Top Pharmaceuticals Paying Substantial Dividends
Seeking Alpha
Sunday, October 14, 2012 - 11:19am
tags:
Bristol-Myers Squibb, JNJ, Eli Lilly, Pfizer, Merck
2 Biotech Companies Investors Should Watch As Analysts Initiate Buy Ratings
Seeking Alpha
Sunday, October 14, 2012 - 11:13am
tags:
AcelRx, Meridian Bioscience
Watson's Generic Sanctura XR Receives FDA Approval
Melodika
Sunday, October 14, 2012 - 11:11am
tags:
Watson Pharmaceuticals, Sanctura XR, generics
Why Is Eli Lilly Climbing?
Motley Fool
Sunday, October 14, 2012 - 11:09am
tags:
Eli Lilly
India Patent Authority Has Big Pharma Worried
Connecticut Law Tribune, CT
Sunday, October 14, 2012 - 11:08am
tags:
patents
NPS Pharmaceuticals: Buy If There Is A Dip
Seeking Alpha
Sunday, October 14, 2012 - 11:06am
tags:
NPS Pharmaceuticals, Gattex, short bowel syndrome
Biotech Weekend Recap: Clinical Trials, Company Files
Seeking Alpha
Sunday, October 14, 2012 - 11:04am
tags:
Eli Lilly, Valeant Pharmaceuticals, Lexicon Pharmaceuticals, Sarepta Therapeutics, Amarin, NPS Pharmaceuticals, Aeterna Zentaris
2 Biotech Stocks Ready To Flourish In The Wake Of Very Significant FDA News
Seeking Alpha
Sunday, October 14, 2012 - 11:02am
tags:
Celgene, NPS Pharmaceuticals, lung cancer, Abraxane, Gattex, short bowel syndrome
Questcor Pharmaceuticals: Turning Bullish As Volatility Continues
Seeking Alpha
Sunday, October 14, 2012 - 10:59am
tags:
Questcor Pharmaceuticals
Our Fourth Nominee for Worst CEO of the Year: Lamberto Andreotti
Motley Fool
Sunday, October 14, 2012 - 10:57am
tags:
Bristol-Myers Squibb, Lamberto Andreotti
United States : White & Case Secures Victory in AndroGel Antitrust Class Actions
equities.com
Saturday, October 13, 2012 - 12:46pm
tags:
patents, Par Pharmaceutical, Paddock Laboratories, lawsuits, generics, Androgel

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.